# Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study

> **NCT01865162** · PHASE1 · COMPLETED · sponsor: **Mid-Atlantic Epilepsy and Sleep Center, LLC** · enrollment: 6 (estimated)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **OTHER:** ketogenic diet

## Key facts

- **NCT ID:** NCT01865162
- **Lead sponsor:** Mid-Atlantic Epilepsy and Sleep Center, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2021-01
- **Final completion:** 2021-01
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2022-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01865162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01865162, "Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01865162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*